This thesis expands the evidence base for the long-term outcomes of children and adolescents with Cerebral Palsy (CP) treated with Botulinum toxin (BoNTA). A cohort of children with CP in WA who have been managed with BoNTA since 1995 were studied and our results confirm long-term use of BoNTA is associated with gross motor stability when used within evidence-based guidelines and in a model of goal-based decision making by a multidisciplinary team. It is important to consider dose and frequency to ensure muscle recovery from the neurogenic atrophy effects of BoNTA and ensure muscle strength is maximised post BoNTA use.
|Qualification||Doctor of Philosophy|
|Award date||2 Jan 2020|
|Publication status||Unpublished - 2020|